Drugs / VRC-WEVVLP073-00-VP
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03879603 | Apr 2019 → Feb 2020 | Venezuelan equine encephalitis, eastern equine encephalitis, western equine encephalitis | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VRC-WEVVLP073-00-VP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03879603 ↗ |
| Modality | Vaccine | “investigational trivalent virus-like particle (VLP) vaccine” PMID 35568049 ↗ May 2022 |
| Route | Intramuscular | “The product was administered in the upper arm muscle as an intramuscular (IM) injection” NCT03879603 ↗ |